WallStSmart
HYFT

ImmunoPrecise Antibodies Ltd.

NASDAQ: HYFT · HEALTHCARE · BIOTECHNOLOGY

$1.19
+0.00% today

Updated 2026-04-30

Market cap
$54.19M
P/E ratio
P/S ratio
1.93x
EPS (TTM)
$-0.10
Dividend yield
52W range
$0 – $3
Volume
0.3M

ImmunoPrecise Antibodies Ltd. (HYFT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-110586.00$-297309.00$-523449.00$-155678.00$-308492.00$-80386.00$-132715.00$-4335.00$-46602.00$-36106.00$284087.00$-721651.00$-3.42M$-3.21M$-1.39M$-600000.00$-9.92M$-19.83M$-4.25M$-6.41M
Capital expenditures$1.85M$1.82M$105039.00$1.39M$322809.00$13655.00$1639.00$0.00$0.00$20316.00$17480.00$530750.00$345487.00$645058.00$575642.00$1.43M$1.26M$1.50M$1.40M$799000.00
Depreciation
Stock-based comp$113436.00$30077.00$198032.00$1.22M$1.11M$739011.00$2.75M$3.08M$1.94M$1.53M$445000.00
Free cash flow$-1.96M$-2.12M$-628488.00$-1.54M$-631301.00$-94041.00$-134354.00$-4335.00$-46602.00$-56422.00$266607.00$-1.25M$-3.76M$-3.85M$-1.97M$-2.03M$-11.18M$-21.33M$-5.64M$-7.21M
Investing cash flow
Financing cash flow
Dividends paid$200000.00$65000.00$90000.00
Share repurchases
Debt repayment
Net change in cash